V. M. Knepp

Controlled drug release from a novel liposomal delivery system. II. Transdermal delivery characteristics

R. Guy, F. Szoka, V. M. Knepp, 1990 .

Stability of Nonaqueous Suspension Formulations of Plasma Derived Factor IX and Recombinant Human Alpha Interferon at Elevated Temperatures

V. M. Knepp, A. Muchnik, S. Oldmark, 1998, Pharmaceutical Research.

Transdermal drug delivery: problems and possibilities.

J. Hadgraft, V. M. Knepp, R. Guy, 1987, Critical reviews in therapeutic drug carrier systems.

Controlled drug release from a novel liposomal delivery system. I. Investigation of transdermal potential

R. Guy, F. Szoka, V. M. Knepp, 1987 .

Identification of antioxidants for prevention of peroxide-mediated oxidation of recombinant human ciliary neurotrophic factor and recombinant human nerve growth factor.

T. Calderwood, V. M. Knepp, A. Muchnik, 1996, PDA journal of pharmaceutical science and technology.

Quantitative evaluation of the stability and delivery of interleukin-1B by infusion.

G. Visor, T. Calderwood, V. M. Knepp, 1990, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.